Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedFooter revision labels show software version updates (v3.3.1 and v3.2.0) without changing study history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedRemoved the generic government funding/operating status notice from the page header. No trial data, statuses, or contact information were changed.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedNew version entry appears in the history list, showing the latest submission date; core trial content and status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference9%

- Check60 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

- Check68 days agoChange DetectedUpdated page now includes a current date (2025-09-19) and a study status with contacts/locations (dated 2025-09-18), while an older entry dated 2025-06-22 was removed.SummaryDifference1.0%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.